Clinical trials: Structural Heart Abnormality, open to volunteers
Structural Heart Abnormality
Prince of Wales Hospital Structural Heart Registry
Structural heart disease refers to a group of cardiac defects other than coronary artery disease. Structural heart intervention is a rapidly growing field in cardiology.
- Trial name
- NCT07020286
- Testing
- Structural heart interventions
- Where
- Hong Kong
- Volunteers
- 1,000 people
- Sponsor
- Prince of Wales Hospital, Shatin, Hong Kong
Structural Heart Abnormality, Structural Heart Disease
Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation
HEART-AI is a pragmatic randomized trial currently active at Montreal Heart Institute, with planned multicenter expansion testing whether an artificial intelligence (AI) score from a routine 12-lead electrocardiogram (ECG) helps…
- Trial name
- HEART-AI (NCT06462989)
- Testing
- ECHONEXT
- Where
- Canada
- Volunteers
- 5,700 people
- Sponsor
- Montreal Heart Institute
Structural Heart Abnormality, Valve Heart Disease
Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
Doctors are testing a new tool called EchoNext to see if it can help find heart problems earlier. EchoNext looks at the heart's electrical test, called an ECG, and uses artificial intelligence (AI) to check for signs of…
- Conditions
- Structural Heart Abnormality, Valve Heart Disease, Heart Diseases, Cardiovascular Diseases
- Trial name
- CACTUS (NCT07843004)
- Testing
- EHR Alert
- Where
- United States
- Volunteers
- 4,000 people
- Sponsor
- Pierre Elias